Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

664 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma.
Terpos E, Heath DJ, Rahemtulla A, Zervas K, Chantry A, Anagnostopoulos A, Pouli A, Katodritou E, Verrou E, Vervessou EC, Dimopoulos MA, Croucher PI. Terpos E, et al. Among authors: anagnostopoulos a. Br J Haematol. 2006 Dec;135(5):688-92. doi: 10.1111/j.1365-2141.2006.06356.x. Br J Haematol. 2006. PMID: 17107351 Free article.
Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS).
Politou M, Terpos E, Anagnostopoulos A, Szydlo R, Laffan M, Layton M, Apperley JF, Dimopoulos MA, Rahemtulla A. Politou M, et al. Among authors: anagnostopoulos a. Br J Haematol. 2004 Sep;126(5):686-9. doi: 10.1111/j.1365-2141.2004.05092.x. Br J Haematol. 2004. PMID: 15327520 Free article.
Extent of damage and repair in the p53 tumor-suppressor gene after treatment of myeloma patients with high-dose melphalan and autologous blood stem-cell transplantation is individualized and may predict clinical outcome.
Dimopoulos MA, Souliotis VL, Anagnostopoulos A, Papadimitriou C, Sfikakis PP. Dimopoulos MA, et al. Among authors: anagnostopoulos a. J Clin Oncol. 2005 Jul 1;23(19):4381-9. doi: 10.1200/JCO.2005.07.385. Epub 2005 May 9. J Clin Oncol. 2005. PMID: 15883412
Waldenström's macroglobulinemia.
Dimopoulos MA, Anagnostopoulos A. Dimopoulos MA, et al. Among authors: anagnostopoulos a. Best Pract Res Clin Haematol. 2005;18(4):747-65. doi: 10.1016/j.beha.2005.01.028. Best Pract Res Clin Haematol. 2005. PMID: 16026748 Review.
664 results